Indoco Remedies in its press release announced that, its Goa Plant
II & III (Goa Plant-II & III, L-32,33,34, Verna
Industrial Area, Verna, Goa, India) received ‘Form 483’ with seven observations. This is 1 of the 2
USFDA approved facilities owned by the company. Indoco manufactures 24 of the
total 27 formulation products manufactured for the US market in this facility.
This facility manufactures Oral Solids, Injectable and Ophthalmic products.
This report analyses the impact on its marketed products.